Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03357172

Determination of Factors Involved in the Regulation of Immune Responses After Allogeneic Hematopoietic Stem Cell Transplantation

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
700 (estimated)
Sponsor
Central Hospital, Nancy, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study concerns donors and patients receiving allogeneic stem cell haematopoietic transplantation. The aim of the study is to analyse HSC graft content in immune effector T (naive, memory, activated, exhausted) and immunoregulatory cell subtypes (Tregs, iNKT, MDSC) and correlate the results with post-transplant immune reconstitution of those different cell subtypes and clinical events (graft-versus-host-disease, relapse, infections). An ancillary study will focus on the impact of microbiota dysbiosis on post-transplant immune response and regulatory cell subsets.

Conditions

Interventions

TypeNameDescription
BIOLOGICALBlood SampleAdditional blood sample before graft, D0, D7, D15, D21, D30, D60, D90, D180, Y1, Y2
BIOLOGICALBone marrow aspirationAdditional bone marrow aspiration before graft, D30, D90, Y1
BIOLOGICALBlood sampleBefore donation
BIOLOGICALAllogeneic hematopoietic stem cell sampleAllogeneic hematopoietic stem cell sample

Timeline

Start date
2019-10-01
Primary completion
2026-09-30
Completion
2026-09-30
First posted
2017-11-29
Last updated
2019-10-14

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03357172. Inclusion in this directory is not an endorsement.